Clinical Trial Update: A Study of Opaganib in Coronavirus Disease 2019 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial update for opaganib in coronavirus pneumonia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Drugs mentioned

• Opaganib (opaganib)

Snippet

Sponsor: RedHill Biopharma Limited | Conditions: Coronavirus Infections | Phase 2 | Status: COMPLETED | Results posted: 2022-03-21